It was found that adding NB-UVB light therapy to ruxolitinib (Opzelura) 1.5% cream helped many vitiligo patients who did not respond early to treatment achieve faster and more noticeable skin ...

Vitiligo is a long-term skin condition where certain areas lose their natural color and turn noticeably lighter than the ...

The application is supported by data from the phase 3 TRuE-V clinical trial program. The Food and Drug Administration (FDA) has accepted for Priority Review the supplemental New Drug Application for ...

The treatment is known to return the skin back to its natural colour and remove white patches - but before it can be used, it needs to be approved by UK experts. Here is everything you need to know ...

- Treatment with ruxolitinib cream (Opzelura™) resulted in facial repigmentation at Week 24, characterized by a significant proportion of patients achieving ≥75% improvement from baseline in the ...

Superstar Michael Jackson, actor Jon Hamm, fashion model Winnie Harlow. All three had or currently have the condition vitiligo. It's a condition that causes the skin to lose pigment, leaving white ...

Please provide your email address to receive an email when new articles are posted on . You've successfully added to your alerts. You will receive an email when new content is published. Click Here to ...

The FDA approval of topical ruxolitinib 1.5% cream changed the game for vitiligo treatment in both adult and pediatric patients, said Raj Chovatiya, MD, PhD, assistant professor of dermatology at ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Ruxolitinib cream improved facial vitiligo and showed ...

WILMINGTON, Del.--(BUSINESS WIRE)--Incyte (Nasdaq:INCY) today announced that the U.S. Food and Drug Administration (FDA) has accepted for Priority Review the supplemental New Drug Application (sNDA) ...

It’s estimated that more than one million Americans suffer from vitiligo. The autoimmune disorder targets and destroys the pigment cells in the body, causing white patches. The FDA recently approved ...